Modulation of host immunity by the human metapneumovirus

Clinical Microbiology Reviews

Volumn 29, Issue 4, 2016, Pages 795-818

  Céspedes, Pablo F ^a   Palavecino, Christian E ^a   Kalergis, Alexis M ^a,b,c   Bueno, Susan M ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PATTERN RECOGNITION RECEPTOR; VIRULENCE FACTOR;

ARTICLE; DISEASE SEVERITY; GENE SEQUENCE; HERD IMMUNITY; HUMAN METAPNEUMOVIRUS INFECTION; IMMUNE RESPONSE; IMMUNOMODULATION; MICROPHOTOGRAPHY; NONHUMAN; PATHOGENESIS; PNEUMONIA; PROTEIN PROTEIN INTERACTION; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFECTION; SIGNAL TRANSDUCTION; UPREGULATION; VIRAL CLEARANCE; ADAPTIVE IMMUNITY; ANIMAL; DISEASE MODEL; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; METAPNEUMOVIRUS; MOUSE; PARAMYXOVIRUS INFECTION; PATHOLOGY; PHYSIOLOGY; VIROLOGY;

ADAPTIVE IMMUNITY; ANIMALS; DISEASE MODELS, ANIMAL; HOST-PATHOGEN INTERACTIONS; HUMANS; METAPNEUMOVIRUS; MICE; PARAMYXOVIRIDAE INFECTIONS; RESPIRATORY TRACT INFECTIONS;

EID: 84978827608     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00081-15     Document Type: Article

References (266)

1. WHO. 2014. World Health Organization/Global Health Observatory data repository. World Health Organization, Geneva, Switzerland.
2. Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, Bassani DG, Jha P, Campbell H, Walker CF, Cibulskis R, Eisele T, Liu L, Mathers C, Child Health Epidemiology Reference Group of WHO and UNICEF. 2010. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 375: 1969-1987. http://dx.doi.org/10.1016/S0140-6736(10)60549-1.
3. Papenburg J, Boivin G. 2010. The distinguishing features of human metapneumovirus and respiratory syncytial virus. Rev Med Virol 20: 245-260. http://dx.doi.org/10.1002/rmv.651.
4. van den Hoogen BG, de Jong JC, Groen J, Kuiken T, de Groot R, Fouchier RA, Osterhaus AD. 2001. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 7: 719-724. http://dx.doi.org/10.1038/89098.
5. Yang CF, Wang CK, Tollefson SJ, Piyaratna R, Lintao LD, Chu M, Liem A, Mark M, Spaete RR, Crowe JE, Jr, Williams JV. 2009. Genetic diversity and evolution of human metapneumovirus fusion protein over twenty years. Virol J 6: 138. http://dx.doi.org/10.1186/1743-422X-6-138.
6. de Graaf M, Osterhaus AD, Fouchier RA, Holmes EC. 2008. Evolutionary dynamics of human and avian metapneumoviruses. J Gen Virol 89: 2933-2942. http://dx.doi.org/10.1099/vir.0.2008/006957-0.
7. van den Hoogen BG, Herfst S, Sprong L, Cane PA, Forleo-Neto E, de Swart RL, Osterhaus AD, Fouchier RA. 2004. Antigenic and genetic variability of human metapneumoviruses. Emerg Infect Dis 10: 658-666. http://dx.doi.org/10.3201/eid1004.030393.
8. Papenburg J, Carbonneau J, Isabel S, Bergeron MG, Williams JV, De Serres G, Hamelin ME, Boivin G. 2013. Genetic diversity and molecular evolution of the major human metapneumovirus surface glycoproteins over a decade. J Clin Virol 58: 541-547. http://dx.doi.org/10.1016/j.jcv.2013.08.029.
9. Al-Turab M, Chehadeh W, Al-Nakib W. 2015. Phylogenetic analysis of human metapneumovirus detected in hospitalized patients in Kuwait during the years 2009-2011. J Infect Public Health 8: 448-457. http://dx.doi.org/10.1016/j.jiph.2015.01.008.
10. Kahn JS. 2006. Epidemiology of human metapneumovirus. Clin Microbiol Rev 19: 546-557. http://dx.doi.org/10.1128/CMR.00014-06.
11. Schildgen V, van den Hoogen B, Fouchier R, Tripp RA, Alvarez R, Manoha C, Williams J, Schildgen O. 2011. Human metapneumovirus:lessons learned over the first decade. Clin Microbiol Rev 24: 734-754. http://dx.doi.org/10.1128/CMR.00015-11.
12. Crowe JE, Jr. 2004. Human metapneumovirus as a major cause of human respiratory tract disease. Pediatr Infect Dis J 23: S215-S221. http://dx.doi.org/10.1097/01.inf.0000144668.81573.6d.
13. Williams JV, Harris PA, Tollefson SJ, Halburnt-Rush LL, Pingsterhaus JM, Edwards KM, Wright PF, Crowe JE, Jr. 2004. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med 350: 443-450. http://dx.doi.org/10.1056/NEJMoa025472.
14. Williams JV, Wang CK, Yang CF, Tollefson SJ, House FS, Heck JM, Chu M, Brown JB, Lintao LD, Quinto JD, Chu D, Spaete RR, Edwards KM, Wright PF, Crowe JE, Jr. 2006. The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience. J Infect Dis 193: 387-395. http://dx.doi.org/10.1086/499274.
15. Lu G, Gonzalez R, Guo L, Wu C, Wu J, Vernet G, Paranhos-Baccala G, Wang J, Hung T. 2011. Large-scale seroprevalence analysis of human metapneumovirus and human respiratory syncytial virus infections in Beijing, China. Virol J 8: 62. http://dx.doi.org/10.1186/1743-422X-8-62.
16. Lusebrink J, Wiese C, Thiel A, Tillmann RL, Ditt V, Muller A, Schildgen O, Schildgen V. 2010. High seroprevalence of neutralizing capacity against human metapneumovirus in all age groups studied in Bonn, Germany. Clin Vaccine Immunol 17: 481-484. http://dx.doi.org /10.1128/CVI.00398-09.
17. Zeng L, Chen R, Ishigami K, Atsumi M, Koizumi Y, Sato K, Iritani O, Okuro M, Morimoto S. 2011. Association between human metapneumovirus seroprevalence and hypertension in elderly subjects in a longterm care facility. Hypertens Res 34: 474-478. http://dx.doi.org/10.1038/hr.2010.268.
18. Williams JV, Edwards KM, Weinberg GA, Griffin MR, Hall CB, Zhu Y, Szilagyi PG, Wang CK, Yang CF, Silva D, Ye D, Spaete RR, Crowe JE, Jr. 2010. Population-based incidence of human metapneumovirus infection among hospitalized children. J Infect Dis 201: 1890-1898. http://dx.doi.org/10.1086/652782.
19. Williams JV, Crowe JE, Jr, Enriquez R, Minton P, Peebles RS, Jr, Hamilton RG, Higgins S, Griffin M, Hartert TV. 2005. Human metapneumovirus infection plays an etiologic role in acute asthma exacerbations requiring hospitalization in adults. J Infect Dis 192: 1149-1153. http://dx.doi.org/10.1086/444392.
20. Martinello RA, Esper F, Weibel C, Ferguson D, Landry ML, Kahn JS. 2006. Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease. J Infect 53: 248-254. http://dx.doi.org/10.1016/j.jinf.2005.11.010.
21. Ilvan A, Aslan G, Serin MS, Calikoglu M, Yilmaz FM, Tezcan S, Tas D, Ayrik C, Uygungul E, Sezer O, Emekdas G. 2013. Investigation of the presence of human metapneumovirus in patients with chronic obstructive pulmonary disease and asthma and its relationship with the attacks. Mikrobiyol Bul 47:636-649. (In Turkish.) http://dx.doi.org/10.5578/mb.6041.
22. Djamin RS, Uzun S, Snelders E, Kluytmans JJ, Hoogsteden HC, Aerts JG, Van Der Eerden MM. 2015. Occurrence of virus-induced COPD exacerbations during four seasons. Infect Dis (Lond) 47: 96-100. http://dx.doi.org/10.3109/00365548.2014.968866.
23. Dosanjh A. 2015. Respiratory metapneumoviral infection without coinfection in association with acute and chronic lung allograft dysfunction. J Inflamm Res 8: 79-82. http://dx.doi.org/10.2147/JIR.S78259.
24. Chan PK, Tam JS, Lam CW, Chan E, Wu A, Li CK, Buckley TA, Ng KC, Joynt GM, Cheng FW, To KF, Lee N, Hui DS, Cheung JL, Chu I, Liu E, Chung SS, Sung JJ. 2003. Human metapneumovirus detection in patients with severe acute respiratory syndrome. Emerg Infect Dis 9: 1058-1063. http://dx.doi.org/10.3201/eid0909.030304.
25. Poutanen SM, Low DE, Henry B, Finkelstein S, Rose D, Green K, Tellier R, Draker R, Adachi D, Ayers M, Chan AK, Skowronski DM, Salit I, Simor AE, Slutsky AS, Doyle PW, Krajden M, Petric M, Brunham RC, McGeer AJ, National Microbiology Laboratory, Canada, Canadian Severe Acute Respiratory Syndrome Study Team. 2003. Identification of severe acute respiratory syndrome in Canada. N Engl J Med 348: 1995-2005. http://dx.doi.org/10.1056/NEJMoa030634.
26. Vicente D, Montes M, Cilla G, Perez-Trallero E. 2004. Human metapneumovirus and chronic obstructive pulmonary disease. Emerg Infect Dis 10: 1338-1339. http://dx.doi.org/10.3201/eid1007.030633.
27. Boivin G, Abed Y, Pelletier G, Ruel L, Moisan D, Cote S, Peret TC, Erdman DD, Anderson LJ. 2002. Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups. J Infect Dis 186: 1330-1334. http://dx.doi.org/10.1086/344319.
28. Boivin G, De Serres G, Cote S, Gilca R, Abed Y, Rochette L, Bergeron MG, Dery P. 2003. Human metapneumovirus infections in hospitalized children. Emerg Infect Dis 9: 634-640. http://dx.doi.org /10.3201/eid0906.030017.
29. Louie JK, Schnurr DP, Pan CY, Kiang D, Carter C, Tougaw S, Ventura J, Norman A, Belmusto V, Rosenberg J, Trochet G. 2007. A summer outbreak of human metapneumovirus infection in a long-term-care facility. J Infect Dis 196: 705-708. http://dx.doi.org/10.1086/519846.
30. Hopkins P, McNeil K, Kermeen F, Musk M, McQueen E, Mackay I, Sloots T, Nissen M. 2008. Human metapneumovirus in lung transplant recipients and comparison to respiratory syncytial virus. Am J Respir Crit Care Med 178: 876-881. http://dx.doi.org/10.1164/rccm.200711-1657OC.
31. Walsh EE, Peterson DR, Falsey AR. 2008. Human metapneumovirus infections in adults: another piece of the puzzle. Arch Intern Med 168: 2489-2496. http://dx.doi.org/10.1001/archinte.168.22.2489.
32. Syha R, Beck R, Hetzel J, Ketelsen D, Grosse U, Springer F, Horger M. 2012. Human metapneumovirus (HMPV) associated pulmonary infections in immunocompromised adults-initial CT findings, disease course and comparison to respiratory-syncytial-virus (RSV) induced pulmonary infections. Eur J Radiol 81: 4173-4178. http://dx.doi.org/10.1016/j.ejrad.2012.06.024.
33. Matsuda S, Nakamura M, Hirano E, Kiyota N, Omura T, Suzuki Y, Noda M, Kimura H. 2013. Characteristics of human metapneumovirus infection prevailing in hospital wards housing patients with severe disabilities. Jpn J Infect Dis 66: 195-200. http://dx.doi.org/10.7883/yoken.66.195.
34. Talaat KR, Karron RA, Thumar B, McMahon BA, Schmidt AC, Collins PL, Buchholz UJ. 2013. Experimental infection of adults with recombinant wild-type human metapneumovirus. J Infect Dis 208: 1669-1678. http://dx.doi.org/10.1093/infdis/jit356.
35. Haas LE, de Rijk NX, Thijsen SF. 2012. Human metapneumovirus infections on the ICU: a report of three cases. Ann Intensive Care 2: 30. http://dx.doi.org/10.1186/2110-5820-2-30.
36. Souza JS, Watanabe A, Carraro E, Granato C, Bellei N. 2013. Severe metapneumovirus infections among immunocompetent and immunocompromised patients admitted to hospital with respiratory infection. J Med Virol 85: 530-536. http://dx.doi.org/10.1002/jmv.23477.
37. Arnold JC, Singh KK, Milder E, Spector SA, Sawyer MH, Gavali S, Glaser C. 2009. Human metapneumovirus associated with central nervous system infection in children. Pediatr Infect Dis J 28: 1057-1060. http://dx.doi.org/10.1097/INF.0b013e3181acd221.
38. Schildgen O, Glatzel T, Geikowski T, Scheibner B, Matz B, Bindl L, Born M, Viazov S, Wilkesmann A, Knopfle G, Roggendorf M, Simon A. 2005. Human metapneumovirus RNA in encephalitis patient. Emerg Infect Dis 11: 467-470. http://dx.doi.org/10.3201/eid1103.040676.
39. Sanchez Fernandez I, Rebollo Polo M, Munoz-Almagro C, Monfort Carretero L, Fernandez Urena S, Rueda Munoz A, Colome Roura R, Perez Duenas B. 2012. Human metapneumovirus in the cerebrospinal fluid of a patient with acute encephalitis. Arch Neurol 69: 649-652. http://dx.doi.org/10.1001/archneurol.2011.1094.
40. Yokota T, Enoki H. 2013. Acute encephalopathy associated with human metapneumovirus: a case report. No To Hattatsu 45:461-462. (In Japanese.)
41. Niizuma T, Okumura A, Kinoshita K, Shimizu T. 2014. Acute encephalopathy associated with human metapneumovirus infection. Jpn J Infect Dis 67: 213-215. http://dx.doi.org/10.7883/yoken.67.213.
42. Webster DL, Gardner AH, Dye TJ, Chima RS. 2014. Status epilepticus:a possible association with human metapneumovirus infection. Pediatrics 133: e747-e750. http://dx.doi.org/10.1542/peds.2013-0929.
43. Fok A, Mateevici C, Lin B, Chandra RV, Chong VH. 2015. Encephalitis-associated human metapneumovirus pneumonia in adult, Australia. Emerg Infect Dis 21: 2074-2076. http://dx.doi.org/10.3201/eid2111.150608.
44. Vehapoglu A, Turel O, Uygur Sahin T, Kutlu NO, Iscan A. 2015. Clinical significance of human metapneumovirus in refractory status epilepticus and encephalitis: case report and review of the literature. Case Rep Neurol Med 2015: 131780. http://dx.doi.org/10.1155/2015/131780.
45. Hata M, Ito M, Kiyosawa S, Kimpara Y, Tanaka S, Yamashita T, Hasegawa A, Kobayashi S, Koyama N, Minagawa H. 2007. A fatal case of encephalopathy possibly associated with human metapneumovirus infection. Jpn J Infect Dis 60: 328-329.
46. Kaida A, Iritani N, Kubo H, Shiomi M, Kohdera U, Murakami T. 2006. Seasonal distribution and phylogenetic analysis of human metapneumovirus among children in Osaka City, Japan. J Clin Virol 35: 394-399. http://dx.doi.org/10.1016/j.jcv.2005.12.009.
47. Williams JV, Martino R, Rabella N, Otegui M, Parody R, Heck JM, Crowe JE, Jr. 2005. A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections. J Infect Dis 192: 1061-1065. http://dx.doi.org/10.1086/432732.
48. Dokos C, Masjosthusmann K, Rellensmann G, Werner C, Schuler-Luttmann S, Muller KM, Schiborr M, Ehlert K, Groll AH. 2013. Fatal human metapneumovirus infection following allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 15: E97-E101. http://dx.doi.org/10.1111/tid.12074.
49. Te Wierik MJ, Nguyen DT, Beersma MF, Thijsen SF, Heemstra KA. 2012. An outbreak of severe respiratory tract infection caused by human metapneumovirus in a residential care facility for elderly in Utrecht, the Netherlands, January to March 2010. Euro Surveill 17(3):pii-20132. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId-20132.
50. Liao RS, Appelgate DM, Pelz RK. 2012. An outbreak of severe respiratory tract infection due to human metapneumovirus in a long-term care facility for the elderly in Oregon. J Clin Virol 53: 171-173. http://dx.doi.org/10.1016/j.jcv.2011.10.010.
51. Edwards KM, Zhu Y, Griffin MR, Weinberg GA, Hall CB, Szilagyi PG, Staat MA, Iwane M, Prill MM, Williams JV, New Vaccine Surveillance Network. 2013. Burden of human metapneumovirus infection in young children. N Engl J Med 368: 633-643. http://dx.doi.org/10.1056/NEJMoa1204630.
52. Falsey AR, McElhaney JE, Beran J, van Essen GA, Duval X, Esen M, Galtier F, Gervais P, Hwang SJ, Kremsner P, Launay O, Leroux-Roels G, McNeil SA, Nowakowski A, Richardus JH, Ruiz-Palacios G, St Rose S, Devaster JM, Oostvogels L, Durviaux S, Taylor S. 2014. Respiratory syncytial virus and other respiratory viral infections in older adults with moderate to severe influenza-like illness. J Infect Dis 209: 1873-1881. http://dx.doi.org/10.1093/infdis/jit839.
53. Schuster JE, Khuri-Bulos N, Faouri S, Shehabi A, Johnson M, Wang L, Fonnesbeck C, Williams JV, Halasa N. 2015. Human metapneumovirus infection in Jordanian children: epidemiology and risk factors for severe disease. Pediatr Infect Dis J 34: 1335-1341. http://dx.doi.org/10.1097/INF.0000000000000892.
54. Papenburg J, Hamelin ME, Ouhoummane N, Carbonneau J, Ouakki M, Raymond F, Robitaille L, Corbeil J, Caouette G, Frenette L, De Serres G, Boivin G. 2012. Comparison of risk factors for human metapneumovirus and respiratory syncytial virus disease severity in young children. J Infect Dis 206: 178-189. http://dx.doi.org/10.1093/infdis /jis333.
55. Hasvold J, Sjoding M, Pohl K, Cooke C, Hyzy RC. 2016. The role of human metapneumovirus in the critically ill adult patient. J Crit Care 31: 233-237. http://dx.doi.org/10.1016/j.jcrc.2015.09.035.
56. Bosis S, Esposito S, Osterhaus AD, Tremolati E, Begliatti E, Tagliabue C, Corti F, Principi N, Niesters HG. 2008. Association between high nasopharyngeal viral load and disease severity in children with human metapneumovirus infection. J Clin Virol 42: 286-290. http://dx.doi.org /10.1016/j.jcv.2008.03.029.
57. Martin ET, Kuypers J, Heugel J, Englund JA. 2008. Clinical disease and viral load in children infected with respiratory syncytial virus or human metapneumovirus. Diagn Microbiol Infect Dis 62: 382-388. http://dx.doi.org/10.1016/j.diagmicrobio.2008.08.002.
58. Roussy JF, Carbonneau J, Ouakki M, Papenburg J, Hamelin ME, De Serres G, Boivin G. 2014. Human metapneumovirus viral load is an important risk factor for disease severity in young children. J Clin Virol 60: 133-140. http://dx.doi.org/10.1016/j.jcv.2014.03.001.
59. Farber DL, Yudanin NA, Restifo NP. 2014. Human memory T cells:generation, compartmentalization and homeostasis. Nat Rev Immunol 14: 24-35. http://dx.doi.org/10.1038/nri3567.
60. + T cells throughout life, from newborns to centenarians: implications for T cell memory. Mech Ageing Dev 86: 173-195. http://dx.doi.org/10.1016/0047-6374(95)01691-0.
61. Saule P, Trauet J, Dutriez V, Lekeux V, Dessaint JP, Labalette M. 2006. Accumulation of memory T cells from childhood to old age: central and effector memory cells in CD4(+) versus effector memory and terminally differentiated memory cells in CD8(+) compartment. Mech Ageing Dev 127: 274-281. http://dx.doi.org/10.1016/j.mad.2005.11.001.
62. Williams JV, Weitkamp JH, Blum DL, LaFleur BJ, Crowe JE, Jr. 2009. The human neonatal B cell response to respiratory syncytial virus uses a biased antibody variable gene repertoire that lacks somatic mutations. Mol Immunol 47: 407-414. http://dx.doi.org/10.1016/j.molimm.2009.08.024.
63. Pancham K, Sami I, Perez GF, Huseni S, Kurdi B, Rose MC, Rodriguez-Martinez CE, Nino G. 23 May 2015. Human metapneumovirus infection is associated with severe respiratory disease in preschool children with history of prematurity. Pediatr Neonatol http://dx.doi.org/10.1016/j.pedneo.2015.03.008.
64. Pancham K, Perez GF, Huseni S, Jain A, Kurdi B, Rodriguez-Martinez CE, Preciado D, Rose MC, Nino G. 2015. Premature infants have impaired airway antiviral IFNgamma responses to human metapneumovirus compared to respiratory syncytial virus. Pediatr Res 78: 389-394. http://dx.doi.org/10.1038/pr.2015.113.
65. El Kholy AA, Mostafa NA, Ali AA, El-Sherbini SA, Ismail RI, Magdy RI, Soliman MS, Said MM. 2014. Risk factors of prolonged hospital stay in children with viral severe acute respiratory infections. J Infect Dev Ctries 8: 1285-1293. http://dx.doi.org/10.3855/jidc.4682.
66. Hoellein A, Hecker J, Hoffmann D, Gottle F, Protzer U, Peschel C, Gotze K. 30 June 2015. Serious outbreak of human metapneumovirus in patients with hematologic malignancies. Leuk Lymphoma http://dx.doi.org/10.3109/10428194.2015.1067699.
67. Godet C, Le Goff J, Beby-Defaux A, Robin M, Raffoux E, Arnulf B, Roblot F, Frat JP, Maillard N, Tazi A, Bergeron A. 2014. Human metapneumovirus pneumonia in patients with hematological malignancies. J Clin Virol 61: 593-596. http://dx.doi.org/10.1016/j.jcv.2014.08.019.
68. Chu HY, Renaud C, Ficken E, Thomson B, Kuypers J, Englund JA. 2014. Respiratory tract infections due to human metapneumovirus in immunocompromised children. J Pediatr Infect Dis Soc 3: 286-293. http://dx.doi.org/10.1093/jpids/piu100.
69. Walker E, Ison MG. 2014. Respiratory viral infections among hospitalized adults: experience of a single tertiary healthcare hospital. Influenza Other Respir Viruses 8: 282-292. http://dx.doi.org/10.1111/irv.12237.
70. Renaud C, Xie H, Seo S, Kuypers J, Cent A, Corey L, Leisenring W, Boeckh M, Englund JA. 2013. Mortality rates of human metapneumovirus and respiratory syncytial virus lower respiratory tract infections in hematopoietic cell transplantation recipients. Biol Blood Marrow Transplant 19: 1220-1226. http://dx.doi.org/10.1016/j.bbmt.2013.05.005.
71. Ali M, Baker JM, Richardson SE, Weitzman S, Allen U, Abla O. 2013. Human metapneumovirus (hMPV) infection in children with cancer. J Pediatr Hematol Oncol 35: 444-446. http://dx.doi.org/10.1097/MPH.0b013e31828ac89c.
72. Noel N, Rammaert B, Zuber J, Sayre N, Mamzer-Bruneel MF, Leruez-Ville M, Mascard L, Lecuit M, Lortholary O. 2012. Lower respiratory tract infection in a renal transplant recipient: do not forget metapneumovirus. Case Rep Transplant 2012: 353871. http://dx.doi.org/10.1155/2012/353871.
73. Englund JA, Boeckh M, Kuypers J, Nichols WG, Hackman RC, Morrow RA, Fredricks DN, Corey L. 2006. Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipients. Ann Intern Med 144: 344-349. http://dx.doi.org/10.7326/0003-4819-144-5-200603070-00010.
74. Wei HY, Tsao KC, Huang CG, Huang YC, Lin TY. 2013. Clinical features of different genotypes/genogroups of human metapneumovirus in hospitalized children. J Microbiol Immunol Infect 46: 352-357. http://dx.doi.org/10.1016/j.jmii.2012.07.007.
75. Arnott A, Vong S, Sek M, Naughtin M, Beaute J, Rith S, Guillard B, Deubel V, Buchy P. 2013. Genetic variability of human metapneumovirus amongst an all ages population in Cambodia between 2007 and 2009. Infect Genet Evol 15: 43-52. http://dx.doi.org/10.1016/j.meegid.2011.01.016.
76. Agapov E, Sumino KC, Gaudreault-Keener M, Storch GA, Holtzman MJ. 2006. Genetic variability of human metapneumovirus infection: evidence of a shift in viral genotype without a change in illness. J Infect Dis 193: 396-403. http://dx.doi.org/10.1086/499310.
77. Kim HR, Cho AR, Lee MK, Yun SW, Kim TH. 2012. Genotype variability and clinical features of human metapneumovirus isolated from Korean children, 2007 to 2010. J Mol Diagn 14: 61-64. http://dx.doi.org/10.1016/j.jmoldx.2011.09.004.
78. van den Hoogen BG, Bestebroer TM, Osterhaus AD, Fouchier RA. 2002. Analysis of the genomic sequence of a human metapneumovirus. Virology 295: 119-132. http://dx.doi.org/10.1006/viro.2001.1355.
79. Biacchesi S, Skiadopoulos MH, Tran KC, Murphy BR, Collins PL, Buchholz UJ. 2004. Recovery of human metapneumovirus from cDNA:optimization of growth in vitro and expression of additional genes. Virology 321: 247-259. http://dx.doi.org/10.1016/j.virol.2003.12.020.
80. Herfst S, de Graaf M, Schickli JH, Tang RS, Kaur J, Yang CF, Spaete RR, Haller AA, van den Hoogen BG, Osterhaus AD, Fouchier RA. 2004. Recovery of human metapneumovirus genetic lineages A and B from cloned cDNA. J Virol 78: 8264-8270. http://dx.doi.org/10.1128/JVI.78.15.8264-8270.2004.
81. Collins PL, Wertz GW. 1983. cDNA cloning and transcriptional mapping of nine polyadenylylated RNAs encoded by the genome of human respiratory syncytial virus. Proc Natl Acad Sci U S A 80: 3208-3212. http://dx.doi.org/10.1073/pnas.80.11.3208.
82. Dickens LE, Collins PL, Wertz GW. 1984. Transcriptional mapping of human respiratory syncytial virus. J Virol 52: 364-369.
83. Biacchesi S, Skiadopoulos MH, Boivin G, Hanson CT, Murphy BR, Collins PL, Buchholz UJ. 2003. Genetic diversity between human metapneumovirus subgroups. Virology 315: 1-9. http://dx.doi.org/10.1016/S0042-6822(03)00528-2.
84. Lamb RA, Parks GD. 2013. Paramyxoviridae, p 957-995. In Knipe DM, Howley PM, Cohen JI, Griffin DE, Lamb RA, Martin MA, Racaniello VR, Roizman B (ed), Fields virology, 6th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
85. Buchholz UJ, Biacchesi S, Pham QN, Tran KC, Yang L, Luongo CL, Skiadopoulos MH, Murphy BR, Collins PL. 2005. Deletion of M2 gene open reading frames 1 and 2 of human metapneumovirus: effects on RNA synthesis, attenuation, and immunogenicity. J Virol 79: 6588-6597. http://dx.doi.org/10.1128/JVI.79.11.6588-6597.2005.
86. Bakker SE, Duquerroy S, Galloux M, Loney C, Conner E, Eleouet JF, Rey FA, Bhella D. 2013. The respiratory syncytial virus nucleoprotein-RNA complex forms a left-handed helical nucleocapsid. J Gen Virol 94: 1734-1738. http://dx.doi.org/10.1099/vir.0.053025-0.
87. El Omari K, Dhaliwal B, Ren J, Abrescia NG, Lockyer M, Powell KL, Hawkins AR, Stammers DK. 2011. Structures of respiratory syncytial virus nucleocapsid protein from two crystal forms: details of potential packing interactions in the native helical form. Acta Crystallogr Sect F Struct Biol Cryst Commun 67: 1179-1183. http://dx.doi.org/10.1107/S1744309111029228.
88. Tawar RG, Duquerroy S, Vonrhein C, Varela PF, Damier-Piolle L, Castagne N, MacLellan K, Bedouelle H, Bricogne G, Bhella D, Eleouet JF, Rey FA. 2009. Crystal structure of a nucleocapsid-like nucleoprotein-RNA complex of respiratory syncytial virus. Science 326: 1279-1283. http://dx.doi.org/10.1126/science.1177634.
89. de Graaf M, Herfst S, Schrauwen EJ, Choi Y, van den Hoogen BG, Osterhaus AD, Fouchier RA. 2008. Specificity and functional interaction of the polymerase complex proteins of human and avian metapneumoviruses. J Gen Virol 89: 975-983. http://dx.doi.org/10.1099/vir.0.83537-0.
90. Dochow M, Krumm SA, Crowe JE, Jr, Moore ML, Plemper RK. 2012. Independent structural domains in paramyxovirus polymerase protein. J Biol Chem 287: 6878-6891. http://dx.doi.org/10.1074/jbc.M111.325258.
91. Zhang Y, Wei Y, Zhang X, Cai H, Niewiesk S, Li J. 2014. Rational design of human metapneumovirus live attenuated vaccine candidates by inhibiting viral mRNA cap methyltransferase. J Virol 88: 11411-11429. http://dx.doi.org/10.1128/JVI.00876-14.
92. Asenjo A, Calvo E, Villanueva N. 2006. Phosphorylation of human respiratory syncytial virus P protein at threonine 108 controls its interaction with the M2-1 protein in the viral RNA polymerase complex. J Gen Virol 87: 3637-3642. http://dx.doi.org/10.1099/vir.0.82165-0.
93. Derdowski A, Peters TR, Glover N, Qian R, Utley TJ, Burnett A, Williams JV, Spearman P, Crowe JE, Jr. 2008. Human metapneumovirus nucleoprotein and phosphoprotein interact and provide the minimal requirements for inclusion body formation. J Gen Virol 89: 2698-2708. http://dx.doi.org/10.1099/vir.0.2008/004051-0.
94. Barik S, McLean T, Dupuy LC. 1995. Phosphorylation of Ser232 directly regulates the transcriptional activity of the P protein of human respiratory syncytial virus: phosphorylation of Ser237 may play an accessory role. Virology 213: 405-412. http://dx.doi.org/10.1006/viro.1995.0013.
95. Dupuy LC, Dobson S, Bitko V, Barik S. 1999. Casein kinase 2-mediated phosphorylation of respiratory syncytial virus phosphoprotein P is essential for the transcription elongation activity of the viral polymerase; phosphorylation by casein kinase 1 occurs mainly at Ser(215) and is without effect. J Virol 73: 8384-8392.
96. Bastien N, Normand S, Taylor T, Ward D, Peret TC, Boivin G, Anderson LJ, Li Y. 2003. Sequence analysis of the N, P,Mand F genes of Canadian human metapneumovirus strains. Virus Res 93: 51-62. http://dx.doi.org/10.1016/S0168-1702(03)00065-0.
97. Palavecino CE, Cespedes PF, Gomez RS, Kalergis AM, Bueno SM. 2014. Immunization with a recombinant bacillus Calmette-Guerin strain confers protective Th1 immunity against the human metapneumovirus. J Immunol 192: 214-223. http://dx.doi.org/10.4049/jimmunol.1300118.
98. Schickli JH, Kaur J, Macphail M, Guzzetta JM, Spaete RR, Tang RS. 2008. Deletion of human metapneumovirus M2-2 increases mutation frequency and attenuates growth in hamsters. Virol J 5: 69. http://dx.doi.org/10.1186/1743-422X-5-69.
99. Cai H, Zhang Y, Ma Y, Sun J, Liang X, Li J. 2015. Zinc binding activity of human metapneumovirus M2-1 protein is indispensable for viral replication and pathogenesis in vivo. J Virol 89: 6391-6405. http://dx.doi.org/10.1128/JVI.03488-14.
100. Leyrat C, Renner M, Harlos K, Huiskonen JT, Grimes JM. 2014. Drastic changes in conformational dynamics of the antiterminator M2-1 regulate transcription efficiency in Pneumovirinae. eLife 3: e02674. http://dx.doi.org/10.7554/eLife.02674.
101. Esperante SA, Noval MG, Altieri TA, de Oliveira GA, Silva JL, de Prat-Gay G. 2013. Fine modulation of the respiratory syncytial virus M2-1 protein quaternary structure by reversible zinc removal from its Cys(3)-His(1) motif. Biochemistry 52: 6779-6789. http://dx.doi.org/10.1021/bi401029q.
102. Kitagawa Y, Zhou M, Yamaguchi M, Komatsu T, Takeuchi K, Itoh M, Gotoh B. 2010. Human metapneumovirus M2-2 protein inhibits viral transcription and replication. Microbes Infect 12: 135-145. http://dx.doi.org/10.1016/j.micinf.2009.11.002.
103. Biacchesi S, Pham QN, Skiadopoulos MH, Murphy BR, Collins PL, Buchholz UJ. 2005. Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidates. J Virol 79: 12608-12613. http://dx.doi.org/10.1128/JVI.79.19.12608-12613.2005.
104. Sabo Y, Ehrlich M, Bacharach E. 2011. The conserved YAGL motif in human metapneumovirus is required for higher-order cellular assemblies of the matrix protein and for virion production. J Virol 85: 6594-6609. http://dx.doi.org/10.1128/JVI.02694-10.
105. Leyrat C, Renner M, Harlos K, Huiskonen JT, Grimes JM. 2014. Structure and self-assembly of the calcium binding matrix protein of human metapneumovirus. Structure 22: 136-148. http://dx.doi.org/10.1016/j.str.2013.10.013.
106. Ghildyal R, Li D, Peroulis I, Shields B, Bardin PG, Teng MN, Collins PL, Meanger J, Mills J. 2005. Interaction between the respiratory syncytial virus G glycoprotein cytoplasmic domain and the matrix protein. J Gen Virol 86: 1879-1884. http://dx.doi.org/10.1099/vir.0.80829-0.
107. Weng Y, Lu W, Harmon A, Xiang X, Deng Q, Song M, Wang D, Yu Q, Li F. 2011. The cellular endosomal sorting complex required for transport pathway is not involved in avian metapneumovirus budding in a virus-like-particle expression system. J Gen Virol 92: 1205-1213. http://dx.doi.org/10.1099/vir.0.029306-0.
108. Cox RG, Livesay SB, Johnson M, Ohi MD, Williams JV. 2012. The human metapneumovirus fusion protein mediates entry via an interaction with RGD-binding integrins. J Virol 86: 12148-12160. http://dx.doi.org/10.1128/JVI.01133-12.
109. Wei Y, Zhang Y, Cai H, Mirza AM, Iorio RM, Peeples ME, Niewiesk S, Li J. 2014. Roles of the putative integrin-binding motif of the human metapneumovirus fusion (F) protein in cell-cell fusion, viral infectivity, and pathogenesis. J Virol 88: 4338-4352. http://dx.doi.org/10.1128/JVI.03491-13.
110. Cseke G, Maginnis MS, Cox RG, Tollefson SJ, Podsiad AB, Wright DW, Dermody TS, Williams JV. 2009. Integrin alphavbeta1 promotes infection by human metapneumovirus. Proc Natl Acad Sci U S A 106: 1566-1571. http://dx.doi.org/10.1073/pnas.0801433106.
111. Chang A, Masante C, Buchholz UJ, Dutch RE. 2012. Human metapneumovirus (HMPV) binding and infection are mediated by interactions between the HMPV fusion protein and heparan sulfate. J Virol 86: 3230-3243. http://dx.doi.org/10.1128/JVI.06706-11.
112. Miller SA, Tollefson S, Crowe JE, Jr, Williams JV, Wright DW. 2007. Examination of a fusogenic hexameric core from human metapneumovirus and identification of a potent synthetic peptide inhibitor from the heptad repeat 1 region. J Virol 81: 141-149. http://dx.doi.org/10.1128/JVI.01243-06.
113. Schowalter RM, Smith SE, Dutch RE. 2006. Characterization of human metapneumovirus F protein-promoted membrane fusion: critical roles for proteolytic processing and low pH. J Virol 80: 10931-10941. http://dx.doi.org/10.1128/JVI.01287-06.
114. Herfst S, Mas V, Ver LS, Wierda RJ, Osterhaus AD, Fouchier RA, Melero JA. 2008. Low-pH-induced membrane fusion mediated by human metapneumovirus F protein is a rare, strain-dependent phenomenon. J Virol 82: 8891-8895. http://dx.doi.org/10.1128/JVI.00472-08.
115. Lamb RA, Jardetzky TS. 2007. Structural basis of viral invasion: lessons from paramyxovirus F. Curr Opin Struct Biol 17: 427-436. http://dx.doi.org/10.1016/j.sbi.2007.08.016.
116. Sorkin A, Von Zastrow M. 2002. Signal transduction and endocytosis:close encounters of many kinds. Nat Rev Mol Cell Biol 3: 600-614. http://dx.doi.org/10.1038/nrm883.
117. Cox RG, Mainou BA, Johnson M, Hastings AK, Schuster JE, Dermody TS, Williams JV. 2015. Human metapneumovirus is capable of entering cells by fusion with endosomal membranes. PLoS Pathog 11: e1005303. http://dx.doi.org/10.1371/journal.ppat.1005303.
118. Thammawat S, Sadlon TA, Hallsworth PG, Gordon DL. 2008. Role of cellular glycosaminoglycans and charged regions of viral G protein in human metapneumovirus infection. J Virol 82: 11767-11774. http://dx.doi.org/10.1128/JVI.01208-08.
119. Adamson P, Thammawat S, Muchondo G, Sadlon T, Gordon D. 2012. Diversity in glycosaminoglycan binding amongst hMPV G protein lineages. Viruses 4: 3785-3803. http://dx.doi.org/10.3390/v4123785.
120. Biacchesi S, Pham QN, Skiadopoulos MH, Murphy BR, Collins PL, Buchholz UJ. 2006. Modification of the trypsin-dependent cleavage activation site of the human metapneumovirus fusion protein to be trypsin independent does not increase replication or spread in rodents or nonhuman primates. J Virol 80: 5798-5806. http://dx.doi.org/10.1128/JVI.00294-06.
121. de Graaf M, Herfst S, Aarbiou J, Burgers PC, Zaaraoui-Boutahar F, Bijl M, van Ijcken W, Schrauwen EJ, Osterhaus AD, Luider TM, Scholte BJ, Fouchier RA, Andeweg AC. 2013. Small hydrophobic protein of human metapneumovirus does not affect virus replication and host gene expression in vitro. PLoS One 8: e58572. http://dx.doi.org/10.1371/journal.pone.0058572.
122. Masante C, El Najjar F, Chang A, Jones A, Moncman CL, Dutch RE. 2014. The human metapneumovirus small hydrophobic protein has properties consistent with those of a viroporin and can modulate viral fusogenic activity. J Virol 88: 6423-6433. http://dx.doi.org/10.1128/JVI.02848-13.
123. + T cell activation. J Virol 88: 6453-6469. http://dx.doi.org /10.1128/JVI.03261-13.
124. Bao X, Kolli D, Liu T, Shan Y, Garofalo RP, Casola A. 2008. Human metapneumovirus small hydrophobic protein inhibits NF-kappaB transcriptional activity. J Virol 82: 8224-8229. http://dx.doi.org/10.1128/JVI.02584-07.
125. Williams JV, Chen Z, Cseke G, Wright DW, Keefer CJ, Tollefson SJ, Hessell A, Podsiad A, Shepherd BE, Sanna PP, Burton DR, Crowe JE, Jr, Williamson RA. 2007. A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo. J Virol 81: 8315-8324. http://dx.doi.org/10.1128/JVI.00106-07.
126. Cseke G, Wright DW, Tollefson SJ, Johnson JE, Crowe JE, Jr, Williams JV. 2007. Human metapneumovirus fusion protein vaccines that are immunogenic and protective in cotton rats. J Virol 81: 698-707. http://dx.doi.org/10.1128/JVI.00844-06.
127. Skiadopoulos MH, Biacchesi S, Buchholz UJ, Amaro-Carambot E, Surman SR, Collins PL, Murphy BR. 2006. Individual contributions of the human metapneumovirus F, G, and SH surface glycoproteins to the induction of neutralizing antibodies and protective immunity. Virology 345: 492-501. http://dx.doi.org/10.1016/j.virol.2005.10.016.
128. Audsley MD, Moseley GW. 2013. Paramyxovirus evasion of innate immunity: diverse strategies for common targets. World J Virol 2: 57-70. http://dx.doi.org/10.5501/wjv.v2.i2.57.
129. Parks GD, Alexander-Miller MA. 2013. Paramyxovirus activation and inhibition of innate immune responses. J Mol Biol 425: 4872-4892. http://dx.doi.org/10.1016/j.jmb.2013.09.015.
130. Vargas SO, Kozakewich HP, Perez-Atayde AR, McAdam AJ. 2004. Pathology of human metapneumovirus infection: insights into the pathogenesis of a newly identified respiratory virus. Pediatr Dev Pathol 7: 478-486; discussion 421. http://dx.doi.org/10.1007/s10024-004-1011-2.
131. Darniot M, Petrella T, Aho S, Pothier P, Manoha C. 2005. Immune response and alteration of pulmonary function after primary human metapneumovirus (hMPV) infection of BALB/c mice. Vaccine 23: 4473-4480. http://dx.doi.org/10.1016/j.vaccine.2005.04.027.
132. Hamelin ME, Prince GA, Gomez AM, Kinkead R, Boivin G. 2006. Human metapneumovirus infection induces long-term pulmonary inflammation associated with airway obstruction and hyperresponsiveness in mice. J Infect Dis 193: 1634-1642. http://dx.doi.org/10.1086/504262.
133. Kuiken T, van den Hoogen BG, van Riel DA, Laman JD, van Amerongen G, Sprong L, Fouchier RA, Osterhaus AD. 2004. Experimental human metapneumovirus infection of cynomolgus macaques (Macaca fascicularis) results in virus replication in ciliated epithelial cells and pneumocytes with associated lesions throughout the respiratory tract. Am J Pathol 164: 1893-1900. http://dx.doi.org /10.1016/S0002-9440(10)63750-9.
134. Debiaggi M, Canducci F, Sampaolo M, Marinozzi MC, Parea M, Terulla C, Colombo AA, Alessandrino EP, Bragotti LZ, Arghittu M, Goglio A, Migliavacca R, Romero E, Clementi M. 2006. Persistent symptomless human metapneumovirus infection in hematopoietic stem cell transplant recipients. J Infect Dis 194: 474-478. http://dx.doi.org/10.1086/505881.
135. Abed Y, Boivin G. 2008. Human metapneumovirus infection in immunocompromised child. Emerg Infect Dis 14: 854-856. http://dx.doi.org /10.3201/eid1405.071459.
136. Evashuk KM, Forgie SE, Gilmour S, Huynh H, Lee BE, Robinson JL. 2008. Respiratory failure associated with human metapneumovirus infection in an infant posthepatic transplant. Am J Transplant 8: 1567-1569. http://dx.doi.org/10.1111/j.1600-6143.2008.02278.x.
137. Gupta A, Bembea M, Brown A, Robertson C, Romer L, Cohn RD. 2012. Respiratory failure secondary to human metapneumovirus requiring extracorporeal membrane oxygenation in a 32-month-old child. Case Rep Pediatr 2012: 268074. http://dx.doi.org/10.1155/2012/268074.
138. Lay MK, Cespedes PF, Palavecino CE, Leon MA, Diaz RA, Salazar FJ, Mendez GP, Bueno SM, Kalergis AM. 15 April 2015. Human metapneumovirus infection activates the TSLP pathway that drives excessive pulmonary inflammation and viral replication in mice. Eur J Immunol http://dx.doi.org/10.1002/eji.201445021.
139. Alvarez R, Harrod KS, Shieh WJ, Zaki S, Tripp RA. 2004. Human metapneumovirus persists in BALB/c mice despite the presence of neutralizing antibodies. J Virol 78: 14003-14011. http://dx.doi.org/10.1128/JVI.78.24.14003-14011.2004.
140. Liu Y, Haas DL, Poore S, Isakovic S, Gahan M, Mahalingam S, Fu ZF, Tripp RA. 2009. Human metapneumovirus establishes persistent infection in the lungs of mice and is reactivated by glucocorticoid treatment. J Virol 83: 6837-6848. http://dx.doi.org/10.1128/JVI.00379-09.
141. Jain S, Williams DJ, Arnold SR, Ampofo K, Bramley AM, Reed C, Stockmann C, Anderson EJ, Grijalva CG, Self WH, Zhu Y, Patel A, Hymas W, Chappell JD, Kaufman RA, Kan JH, Dansie D, Lenny N, Hillyard DR, Haynes LM, Levine M, Lindstrom S, Winchell JM, Katz JM, Erdman D, Schneider E, Hicks LA, Wunderink RG, Edwards KM, Pavia AT, McCullers JA, Finelli L, CDC EPIC Study Team. 2015. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med 372: 835-845. http://dx.doi.org/10.1056/NEJMoa1405870.
142. Homaira N, Luby SP, Petri WA, Vainionpaa R, Rahman M, Hossain K, Snider CB, Rahman M, Alamgir AS, Zesmin F, Alam M, Gurley ES, Zaman RU, Azim T, Erdman DD, Fry AM, Bresee J, Widdowson MA, Haque R, Azziz-Baumgartner E. 2012. Incidence of respiratory virusassociated pneumonia in urban poor young children of Dhaka, Bangla-desh, 2009-2011. PLoS One 7: e32056. http://dx.doi.org/10.1371/journal.pone.0032056.
143. Chang YF, Tsao KC, Liu YC, Chen YC, Yu PC, Huang YC, Chou C. 2015. Diagnosis of human metapneumovirus in patients hospitalized with acute lower respiratory tract infection using a metal-enhanced fluorescence technique. J Virol Methods 213: 151-156. http://dx.doi.org/10.1016/j.jviromet.2014.12.005.
144. Guerrero-Plata A, Casola A, Suarez G, Yu X, Spetch L, Peeples ME, Garofalo RP. 2006. Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus. Am J Respir Cell Mol Biol 34: 320-329. http://dx.doi.org/10.1165/rcmb.2005-0287OC.
145. Cespedes PF, Gonzalez PA, Kalergis AM. 2013. Human metapneumovirus keeps dendritic cells from priming antigen-specific naive T cells. Immunology 139: 366-376. http://dx.doi.org/10.1111/imm.12083.
146. Le Nouen C, Munir S, Losq S, Winter CC, McCarty T, Stephany DA, Holmes KL, Bukreyev A, Rabin RL, Collins PL, Buchholz UJ. 2009. Infection and maturation of monocyte-derived human dendritic cells by human respiratory syncytial virus, human metapneumovirus, and human parainfluenza virus type 3. Virology 385: 169-182. http://dx.doi.org /10.1016/j.virol.2008.11.043.
147. Tan MC, Battini L, Tuyama AC, Macip S, Melendi GA, Horga MA, Gusella GL. 2007. Characterization of human metapneumovirus infection of myeloid dendritic cells. Virology 357: 1-9. http://dx.doi.org/10.1016/j.virol.2006.08.004.
148. Guerrero-Plata A, Kolli D, Hong C, Casola A, Garofalo RP. 2009. Subversion of pulmonary dendritic cell function by paramyxovirus infections. J Immunol 182: 3072-3083. http://dx.doi.org/10.4049/jimmunol.0802262.
149. Kolli D, Gupta MR, Sbrana E, Velayutham TS, Chao H, Casola A, Garofalo RP. 2014. Alveolar macrophages contribute to the pathogenesis of human metapneumovirus infection while protecting against respiratory syncytial virus infection. Am J Respir Cell Mol Biol 51: 502-515. http://dx.doi.org/10.1165/rcmb.2013-0414OC.
150. Ivashkiv LB, Donlin LT. 2014. Regulation of type I interferon responses. Nat Rev Immunol 14: 36-49. http://dx.doi.org/10.1038/nri3581.
151. Riboldi E, Daniele R, Cassatella MA, Sozzani S, Bosisio D. 2009. Engagement of BDCA-2 blocks TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells. Immunobiology 214: 868-876. http://dx.doi.org/10.1016/j.imbio.2009.06.016.
152. Arimori Y, Nakamura R, Yamada H, Shibata K, Maeda N, Kase T, Yoshikai Y. 2014. Type I interferon plays opposing roles in cytotoxicity and interferon-gamma production by natural killer and CD8 T cells after influenzaAvirus infection in mice. J Innate Immun 6: 456-466. http://dx.doi.org/10.1159/000356824.
153. Liao S, Bao X, Liu T, Lai S, Li K, Garofalo RP, Casola A. 2008. Role of retinoic acid inducible gene-I in human metapneumovirus-induced cellular signalling. J Gen Virol 89: 1978-1986. http://dx.doi.org/10.1099/vir.0.2008/000778-0.
154. Bao X, Kolli D, Ren J, Liu T, Garofalo RP, Casola A. 2013. Human metapneumovirus glycoprotein G disrupts mitochondrial signaling in airway epithelial cells. PLoS One 8: e62568. http://dx.doi.org/10.1371/journal.pone.0062568.
155. Goutagny N, Jiang Z, Tian J, Parroche P, Schickli J, Monks BG, Ulbrandt N, Ji H, Kiener PA, Coyle AJ, Fitzgerald KA. 2010. Cell type-specific recognition of human metapneumoviruses (HMPVs) by retinoic acid-inducible gene I (RIG-I) and TLR7 and viral interference of RIG-I ligand recognition by HMPV-B1 phosphoprotein. J Immunol 184: 1168-1179. http://dx.doi.org/10.4049/jimmunol.0902750.
156. Ren J, Wang Q, Kolli D, Prusak DJ, Tseng CT, Chen ZJ, Li K, Wood TG, Bao X. 2012. Human metapneumovirus M2-2 protein inhibits innate cellular signaling by targeting MAVS. J Virol 86: 13049-13061. http://dx.doi.org/10.1128/JVI.01248-12.
157. Banos-Lara MDR, Ghosh A, Guerrero-Plata A. 2013. Critical role of MDA5 in the interferon response induced by human metapneumovirus infection in dendritic cells and in vivo. J Virol 87: 1242-1251. http://dx.doi.org/10.1128/JVI.01213-12.
158. Kolli D, Bao X, Liu T, Hong C, Wang T, Garofalo RP, Casola A. 2011. Human metapneumovirus glycoproteinGinhibits TLR4-dependent signaling in monocyte-derived dendritic cells. J Immunol 187: 47-54. http://dx.doi.org/10.4049/jimmunol.1002589.
159. Hastings AK, Erickson JJ, Schuster JE, Boyd KL, Tollefson SJ, Johnson M, Gilchuk P, Joyce S, Williams JV. 2015. Role of type I interferon signaling in human metapneumovirus pathogenesis and control of viral replication. J Virol 89: 4405-4420. http://dx.doi.org /10.1128/JVI.03275-14.
160. + T cells through PD-1. J Clin Invest 122: 2967-2982. http://dx.doi.org/10.1172/JCI62860.
161. Spann KM, Loh Z, Lynch JP, Ullah A, Zhang V, Baturcam E, Werder RB, Khajornjiraphan N, Rudd P, Loo YM, Suhrbier A, Gale M, Jr, Upham JW, Phipps S. 2014. IRF-3, IRF-7, and IPS-1 promote host defense against acute human metapneumovirus infection in neonatal mice. Am J Pathol 184: 1795-1806. http://dx.doi.org/10.1016/j.ajpath.2014.02.026.
162. Banos-Lara MDR, Harvey L, Mendoza A, Guerrero-Plata A. 2013. Type III interferon induction by HMPV infection in human epithelial cells, abstr A2781. Abstr Am Thorac Soc Int Conf 2013.
163. Banos-Lara MDR, Harvey L, Mendoza A, Simms D, Chouljenko VN, Wakamatsu N, Kousoulas KG, Guerrero-Plata A. 2015. Impact and regulation of lambda interferon response in human metapneumovirus infection. J Virol 89: 730-742. http://dx.doi.org/10.1128/JVI.02897-14.
164. Chi B, Dickensheets HL, Spann KM, Alston MA, Luongo C, Dumoutier L, Huang J, Renauld JC, Kotenko SV, Roederer M, Beeler JA, Donnelly RP, Collins PL, Rabin RL. 2006. Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus. J Virol 80: 5032-5040. http://dx.doi.org/10.1128/JVI.80.10.5032-5040.2006.
165. Ren J, Kolli D, Liu T, Xu R, Garofalo RP, Casola A, Bao X. 2011. Human metapneumovirus inhibits IFN-beta signaling by downregulating Jak1 and Tyk2 cellular levels. PLoS One 6: e24496. http://dx.doi.org /10.1371/journal.pone.0024496.
166. Mitzel DN, Jaramillo RJ, Stout-Delgado H, Senft AP, Harrod KS. 2014. Human metapneumovirus inhibits the IL-6-induced JAK/STAT3 signalling cascade in airway epithelium. J Gen Virol 95: 26-37. http://dx.doi.org/10.1099/vir.0.055632-0.
167. Ren J, Liu G, Go J, Kolli D, Zhang G, Bao X. 2014. Human metapneumovirus M2-2 protein inhibits innate immune response in monocyte-derived dendritic cells. PLoS One 9: e91865. http://dx.doi.org/10.1371/journal.pone.0091865.
168. Bao X, Liu T, Shan Y, Li K, Garofalo RP, Casola A. 2008. Human metapneumovirus glycoprotein G inhibits innate immune responses. PLoS Pathog 4: e1000077. http://dx.doi.org/10.1371/journal.ppat.1000077.
169. Bao X, Sinha M, Liu T, Hong C, Luxon BA, Garofalo RP, Casola A. 2008. Identification of human metapneumovirus-induced gene networks in airway epithelial cells by microarray analysis. Virology 374: 114-127. http://dx.doi.org/10.1016/j.virol.2007.12.024.
170. Wang YH, Ito T, Wang YH, Homey B, Watanabe N, Martin R, Barnes CJ, McIntyre BW, Gilliet M, Kumar R, Yao Z, Liu YJ. 2006. Maintenance and polarization of human TH2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells. Immunity 24: 827-838. http://dx.doi.org/10.1016/j.immuni.2006.03.019.
171. Ito T, Wang YH, Duramad O, Hori T, Delespesse GJ, Watanabe N, Qin FX, Yao Z, Cao W, Liu YJ. 2005. TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med 202: 1213-1223. http://dx.doi.org/10.1084/jem.20051135.
172. Neill DR, Wong SH, Bellosi A, Flynn RJ, Daly M, Langford TK, Bucks C, Kane CM, Fallon PG, Pannell R, Jolin HE, McKenzie AN. 2010. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464: 1367-1370. http://dx.doi.org/10.1038/nature08900.
173. Ford LB, Cerovic V, Milling SW, Graham GJ, Hansell CA, Nibbs RJ. 2014. Characterization of conventional and atypical receptors for the chemokine CCL2 on mouse leukocytes. J Immunol 193: 400-411. http://dx.doi.org/10.4049/jimmunol.1303236.
174. Wang A, Wang Z, Cao Y, Cheng S, Chen H, Bunjhoo H, Xie J, Wang C, Xu Y, Xiong W. 2015. CCL2/CCR2-dependent recruitment of Th17 cells but not Tc17 cells to the lung in a murine asthma model. Int Arch Allergy Immunol 166: 52-62. http://dx.doi.org/10.1159/000371764.
175. Cook DN, Beck MA, Coffman TM, Kirby SL, Sheridan JF, Pragnell IB, Smithies O. 1995. Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science 269: 1583-1585. http://dx.doi.org/10.1126/science.7667639.
176. Wolpe SD, Davatelis G, Sherry B, Beutler B, Hesse DG, Nguyen HT, Moldawer LL, Nathan CF, Lowry SF, Cerami A. 1988. Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. J Exp Med 167: 570-581. http://dx.doi.org /10.1084/jem.167.2.570.
177. Tyner JW, Uchida O, Kajiwara N, Kim EY, Patel AC, O’Sullivan MP, Walter MJ, Schwendener RA, Cook DN, Danoff TM, Holtzman MJ. 2005. CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection. Nat Med 11: 1180-1187. http://dx.doi.org/10.1038/nm1303.
178. Wolpe SD, Sherry B, Juers D, Davatelis G, Yurt RW, Cerami A. 1989. Identification and characterization of macrophage inflammatory protein 2. Proc Natl Acad Sci U S A 86: 612-616. http://dx.doi.org/10.1073/pnas.86.2.612.
179. Li Q, Park PW, Wilson CL, Parks WC. 2002. Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell 111: 635-646. http://dx.doi.org /10.1016/S0092-8674(02)01079-6.
180. Kaur M, Singh D. 2013. Neutrophil chemotaxis caused by chronic obstructive pulmonary disease alveolar macrophages: the role of CXCL8 and the receptors CXCR1/CXCR2. J Pharmacol Exp Ther 347: 173-180. http://dx.doi.org/10.1124/jpet.112.201855.
181. Dufour JH, Dziejman M, Liu MT, Leung JH, Lane TE, Luster AD. 2002. IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol 168: 3195-3204. http://dx.doi.org/10.4049/jimmunol.168.7.3195.
182. Medoff BD, Sauty A, Tager AM, Maclean JA, Smith RN, Mathew A, Dufour JH, Luster AD. 2002. IFN-gamma-inducible protein 10 (CXCL10) contributes to airway hyperreactivity and airway inflammation in a mouse model of asthma. J Immunol 168: 5278-5286. http://dx.doi.org/10.4049/jimmunol.168.10.5278.
183. Cole KE, Strick CA, Paradis TJ, Ogborne KT, Loetscher M, Gladue RP, Lin W, Boyd JG, Moser B, Wood DE, Sahagan BG, Neote K. 1998. Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med 187: 2009-2021. http://dx.doi.org/10.1084/jem.187.12.2009.
184. + T cell-mediated suppression by dendritic cells. Science 299: 1033-1036. http://dx.doi.org/10.1126/science.1078231.
185. Mestas J, Hughes CC. 2004. Of mice and not men: differences between mouse and human immunology. J Immunol 172: 2731-2738. http://dx.doi.org/10.4049/jimmunol.172.5.2731.
186. Guerrero-Plata A, Casola A, Garofalo RP. 2005. Human metapneumovirus induces a profile of lung cytokines distinct from that of respiratory syncytial virus. J Virol 79: 14992-14997. http://dx.doi.org/10.1128/JVI.79.23.14992-14997.2005.
187. Alvarez R, Tripp RA. 2005. The immune response to human metapneumovirus is associated with aberrant immunity and impaired virus clearance in BALB/c mice. J Virol 79: 5971-5978. http://dx.doi.org/10.1128/JVI.79.10.5971-5978.2005.
188. Qiao J, Li A, Jin X. 2011. TSLP from RSV-stimulated rat airway epithelial cells activates myeloid dendritic cells. Immunol Cell Biol 89: 231-238. http://dx.doi.org/10.1038/icb.2010.85.
189. Lee HC, Headley MB, Loo YM, Berlin A, Gale M, Jr, Debley JS, Lukacs NW, Ziegler SF. 2012. Thymic stromal lymphopoietin is induced by respiratory syncytial virus-infected airway epithelial cells and promotes a type 2 response to infection. J Allergy Clin Immunol 130: 1187-1196. http://dx.doi.org/10.1016/j.jaci.2012.07.031.
190. Halfhide CP, Flanagan BF, Brearey SP, Hunt JA, Fonceca AM, Mc-Namara PS, Howarth D, Edwards S, Smyth RL. 2011. Respiratory syncytial virus binds and undergoes transcription in neutrophils from the blood and airways of infants with severe bronchiolitis. J Infect Dis 204: 451-458. http://dx.doi.org/10.1093/infdis/jir280.
191. Inngjerdingen M, Damaj B, Maghazachi AA. 2000. Human NK cells express CC chemokine receptors 4 and 8 and respond to thymus and activation-regulated chemokine, macrophage-derived chemokine, and I-309. J Immunol 164: 4048-4054. http://dx.doi.org/10.4049/jimmunol.164.8.4048.
192. Steinman RM, Cohn ZA. 1973. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 137: 1142-1162.
193. Steinman RM, Cohn ZA. 1974. Identification of a novel cell type in peripheral lymphoid organs of mice. II. Functional properties in vitro. J Exp Med 139: 380-397.
194. Gonzalez PA, Carreno LJ, Coombs D, Mora JE, Palmieri E, Goldstein B, Nathenson SG, Kalergis AM. 2005. T cell receptor binding kinetics required for T cell activation depend on the density of cognate ligand on the antigen-presenting cell. Proc Natl Acad Sci U S A 102: 4824-4829. http://dx.doi.org/10.1073/pnas.0500922102.
195. Vanguri V, Govern CC, Smith R, Huseby ES. 2013. Viral antigen density and confinement time regulate the reactivity pattern of CD4 Tcell responses to vaccinia virus infection. Proc Natl Acad Sci U S A 110: 288-293. http://dx.doi.org/10.1073/pnas.1208328110.
196. Grakoui A, Bromley SK, Sumen C, Davis MM, Shaw AS, Allen PM, Dustin ML. 1999. The immunological synapse: a molecular machine controlling T cell activation. Science 285: 221-227. http://dx.doi.org/10.1126/science.285.5425.221.
197. Wang D, Sun B, Feng M, Feng H, Gong W, Liu Q, Ge S. 2015. Role of scavenger receptors in dendritic cell function. Hum Immunol 76: 442-446. http://dx.doi.org/10.1016/j.humimm.2015.03.012.
198. Hemmi H, Akira S. 2005. TLR signalling and the function of dendritic cells. Chem Immunol Allergy 86: 120-135.
199. Banchereau J, Steinman RM. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252. http://dx.doi.org/10.1038/32588.
200. Tan JK, O’Neill HC. 2005. Maturation requirements for dendritic cells in T cell stimulation leading to tolerance versus immunity. J Leukoc Biol 78: 319-324. http://dx.doi.org/10.1189/jlb.1104664.
201. Quezada SA, Jarvinen LZ, Lind EF, Noelle RJ. 2004. CD40/CD154 interactions at the interface of tolerance and immunity. Annu Rev Immunol 22: 307-328. http://dx.doi.org/10.1146/annurev.immunol.22.012703.104533.
202. Frasca L, Fedele G, Deaglio S, Capuano C, Palazzo R, Vaisitti T, Malavasi F, Ausiello CM. 2006. CD38 orchestrates migration, survival, and Th1 immune response of human mature dendritic cells. Blood 107: 2392-2399. http://dx.doi.org/10.1182/blood-2005-07-2913.
203. Lukacs-Kornek V, Engel D, Tacke F, Kurts C. 2008. The role of chemokines and their receptors in dendritic cell biology. Front Biosci 13: 2238-2252. http://dx.doi.org/10.2741/2838.
204. Gonzalez PA, Carreno LJ, Cespedes PF, Bueno SM, Riedel CA, Kalergis AM. 2013. Modulation of tumor immunity by soluble and membrane-bound molecules at the immunological synapse. Clin Dev Immunol 2013: 450291. http://dx.doi.org/10.1155/2013/450291.
205. Bretscher PA. 1999. A two-step, two-signal model for the primary activation of precursor helper T cells. Proc Natl Acad Sci U S A 96: 185-190. http://dx.doi.org/10.1073/pnas.96.1.185.
206. Le Nouen C, Hillyer P, Winter CC, McCarty T, Rabin RL, Collins PL, Buchholz UJ. 2011. Low CCR7-mediated migration of human monocyte derived dendritic cells in response to human respiratory syncytial virus and human metapneumovirus. PLoS Pathog 7: e1002105. http://dx.doi.org/10.1371/journal.ppat.1002105.
207. Gonzalez PA, Prado CE, Leiva ED, Carreno LJ, Bueno SM, Riedel CA, Kalergis AM. 2008. Respiratory syncytial virus impairs T cell activation by preventing synapse assembly with dendritic cells. Proc Natl Acad Sci U S A 105: 14999-15004. http://dx.doi.org/10.1073/pnas.0802555105.
208. + T cell activation by dendritic cells. PLoS One 5: e15017. http://dx.doi.org/10.1371/journal.pone.0015017.
209. Rothoeft T, Fischer K, Zawatzki S, Schulz V, Schauer U, Korner Rettberg C. 2007. Differential response of human naive and memory/ effector T cells to dendritic cells infected by respiratory syncytial virus. Clin Exp Immunol 150: 263-273. http://dx.doi.org/10.1111/j.1365-2249.2007.03497.x.
210. Cespedes PF, Bueno SM, Ramirez BA, Gomez RS, Riquelme SA, Palavecino CE, Mackern-Oberti JP, Mora JE, Depoil D, Sacristan C, Cammer M, Creneguy A, Nguyen TH, Riedel CA, Dustin ML, Kalergis AM. 2014. Surface expression of the hRSV nucleoprotein impairs immunological synapse formation with T cells. Proc Natl Acad Sci U S A 111: E3214-E3223. http://dx.doi.org/10.1073/pnas.1400760111.
211. Ebihara T, Endo R, Ishiguro N, Nakayama T, Sawada H, Kikuta H. 2004. Early reinfection with human metapneumovirus in an infant. J Clin Microbiol 42: 5944-5946. http://dx.doi.org/10.1128/JCM.42.12.5944-5946.2004.
212. Pavlin JA, Hickey AC, Ulbrandt N, Chan YP, Endy TP, Boukhvalova MS, Chunsuttiwat S, Nisalak A, Libraty DH, Green S, Rothman AL, Ennis FA, Jarman R, Gibbons RV, Broder CC. 2008. Human metapneumovirus reinfection among children in Thailand determined by ELISA using purified soluble fusion protein. J Infect Dis 198: 836-842. http://dx.doi.org/10.1086/591186.
213. Teijaro JR, Verhoeven D, Page CA, Turner D, Farber DL. 2010. Memory CD4 T cells direct protective responses to influenza virus in the lungs through helper-independent mechanisms. J Virol 84: 9217-9226. http://dx.doi.org/10.1128/JVI.01069-10.
214. Olson MR, Seah SG, Cullen J, Greyer M, Edenborough K, Doherty PC, Bedoui S, Lew AM, Turner SJ. 2014. Helping themselves: optimal virus-specific CD4 T cell responses require help via CD4 T cell licensing of dendritic cells. J Immunol 193: 5420-5433. http://dx.doi.org/10.4049/jimmunol.1303359.
215. + T cells protect against influenza through multiple synergizing mechanisms. J Clin Invest 122: 2847-2856. http://dx.doi.org/10.1172/JCI63689.
216. Banerjee S, Sullender WM, Ahuja RK, Broor S. 2011. Seroepidemiological study of human metapneumovirus in New Delhi, India. Indian J Med Microbiol 29: 363-367. http://dx.doi.org/10.4103/0255-0857.90162.
217. Okamoto M, Sugawara K, Takashita E, Muraki Y, Hongo S, Nishimura H, Matsuzaki Y. 2010. Longitudinal course of human metapneumovirus antibody titers and reinfection in healthy adults. J Med Virol 82: 2092-2096. http://dx.doi.org/10.1002/jmv.21920.
218. Herd KA, Nissen MD, Hopkins PM, Sloots TP, Tindle RW. 2008. Major histocompatibility complex class I cytotoxic T lymphocyte immunity to human metapneumovirus (hMPV) in individuals with previous hMPV infection and respiratory disease. J Infect Dis 197: 584-592. http://dx.doi.org/10.1086/526536.
219. Ebihara T, Endo R, Kikuta H, Ishiguro N, Ishiko H, Hara M, Takahashi Y, Kobayashi K. 2004. Human metapneumovirus infection in Japanese children. J Clin Microbiol 42: 126-132. http://dx.doi.org/10.1128/JCM.42.1.126-132.2004.
220. Kolli D, Bataki EL, Spetch L, Guerrero-Plata A, Jewell AM, Piedra PA, Milligan GN, Garofalo RP, Casola A. 2008. T lymphocytes contribute to antiviral immunity and pathogenesis in experimental human metapneumovirus infection. J Virol 82: 8560-8569. http://dx.doi.org/10.1128/JVI.00699-08.
221. Brooks DG, Trifilo MJ, Edelmann KH, Teyton L, McGavern DB, Oldstone MB. 2006. Interleukin-10 determines viral clearance or persistence in vivo. Nat Med 12: 1301-1309. http://dx.doi.org/10.1038/nm1492.
222. Herd KA, Nelson M, Mahalingam S, Tindle RW. 2010. Pulmonary infection of mice with human metapneumovirus induces local cytotoxic T-cell and immunoregulatory cytokine responses similar to those seen with human respiratory syncytial virus. J Gen Virol 91: 1302-1310. http://dx.doi.org/10.1099/vir.0.015396-0.
223. + T cell exhaustion-like phenotype. J Immunol 195: 4319-4330. http://dx.doi.org/10.4049/jimmunol.1403004.
224. Rizzo LV, DeKruyff RH, Umetsu DT. 1992. Generation of B cell memory and affinity maturation. Induction with Th1 and Th2 T cell clones. J Immunol 148: 3733-3739.
225. Herfst S, Fouchier RA. 2008. Vaccination approaches to combat human metapneumovirus lower respiratory tract infections. J Clin Virol 41: 49-52. http://dx.doi.org/10.1016/j.jcv.2007.10.022.
226. MacPhail M, Schickli JH, Tang RS, Kaur J, Robinson C, Fouchier RA, Osterhaus AD, Spaete RR, Haller AA. 2004. Identification of smallanimal and primate models for evaluation of vaccine candidates for human metapneumovirus (hMPV) and implications for hMPV vaccine design. J Gen Virol 85: 1655-1663. http://dx.doi.org/10.1099/vir.0.79805-0.
227. Pham QN, Biacchesi S, Skiadopoulos MH, Murphy BR, Collins PL, Buchholz UJ. 2005. Chimeric recombinant human metapneumoviruses with the nucleoprotein or phosphoprotein open reading frame replaced by that of avian metapneumovirus exhibit improved growth in vitro and attenuation in vivo. J Virol 79: 15114-15122. http://dx.doi.org/10.1128/JVI.79.24.15114-15122.2005.
228. Skiadopoulos MH, Biacchesi S, Buchholz UJ, Riggs JM, Surman SR, Amaro-Carambot E, McAuliffe JM, Elkins WR, St Claire M, Collins PL, Murphy BR. 2004. The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness. J Virol 78: 6927-6937. http://dx.doi.org/10.1128/JVI.78.13.6927-6937.2004.
229. Tang RS, Mahmood K, Macphail M, Guzzetta JM, Haller AA, Liu H, Kaur J, Lawlor HA, Stillman EA, Schickli JH, Fouchier RA, Osterhaus AD, Spaete RR. 2005. A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in African green monkeys. Vaccine 23: 1657-1667. http://dx.doi.org/10.1016/j.vaccine.2004.10.009.
230. Tang RS, Schickli JH, MacPhail M, Fernandes F, Bicha L, Spaete J, Fouchier RA, Osterhaus AD, Spaete R, Haller AA. 2003. Effects of human metapneumovirus and respiratory syncytial virus antigen insertion in two 3= proximal genome positions of bovine/human parainfluenza virus type 3 on virus replication and immunogenicity. J Virol 77: 10819-10828. http://dx.doi.org/10.1128/JVI.77.20.10819-10828.2003.
231. Williams JV, Tollefson SJ, Johnson JE, Crowe JE, Jr. 2005. The cotton rat (Sigmodon hispidus) is a permissive small animal model of human metapneumovirus infection, pathogenesis, and protective immunity. J Virol 79: 10944-10951. http://dx.doi.org/10.1128/JVI.79.17.10944-10951.2005.
232. Cox RG, Erickson JJ, Hastings AK, Becker JC, Johnson M, Craven RE, Tollefson SJ, Boyd KL, Williams JV. 2014. Human metapneumovirus virus-like particles induce protective B and T cell responses in a mouse model. J Virol 88: 6368-6379. http://dx.doi.org/10.1128/JVI.00332-14.
233. Levy C, Aerts L, Hamelin ME, Granier C, Szecsi J, Lavillette D, Boivin G, Cosset FL. 2013. Virus-like particle vaccine induces cross-protection against human metapneumovirus infections in mice. Vaccine 31: 2778-2785. http://dx.doi.org/10.1016/j.vaccine.2013.03.051.
234. Bates JT, Pickens JA, Schuster JE, Johnson M, Tollefson SJ, Williams JV, Davis NL, Johnston RE, Schultz-Darken N, Slaughter JC, Smith-House F, Crowe JE, Jr. 2016. Immunogenicity and efficacy of alphavirus-derived replicon vaccines for respiratory syncytial virus and human metapneumovirus in nonhuman primates. Vaccine 34: 950-956. http://dx.doi.org/10.1016/j.vaccine.2015.12.045.
235. Liu P, Shu Z, Qin X, Dou Y, Zhao Y, Zhao X. 2013. A live attenuated human metapneumovirus vaccine strain provides complete protection against homologous viral infection and cross-protection against heterologous viral infection in BALB/c mice. Clin Vaccine Immunol 20: 1246-1254. http://dx.doi.org/10.1128/CVI.00145-13.
236. Biacchesi S, Skiadopoulos MH, Yang L, Lamirande EW, Tran KC, Murphy BR, Collins PL, Buchholz UJ. 2004. Recombinant human metapneumovirus lacking the small hydrophobic SH and/or attachment G glycoprotein: deletion of G yields a promising vaccine candidate. J Virol 78: 12877-12887. http://dx.doi.org/10.1128/JVI.78.23.12877-12887.2004.
237. Herfst S, Schrauwen EJ, de Graaf M, van Amerongen G, van den Hoogen BG, de Swart RL, Osterhaus AD, Fouchier RA. 2008. Immunogenicity and efficacy of two candidate human metapneumovirus vaccines in cynomolgus macaques. Vaccine 26: 4224-4230. http://dx.doi.org/10.1016/j.vaccine.2008.05.052.
238. Yim KC, Cragin RP, Boukhvalova MS, Blanco JC, Hamlin ME, Boivin G, Porter DD, Prince GA. 2007. Human metapneumovirus: enhanced pulmonary disease in cotton rats immunized with formalin-inactivated virus vaccine and challenged. Vaccine 25: 5034-5040. http://dx.doi.org /10.1016/j.vaccine.2007.04.075.
239. de Swart RL, van den Hoogen BG, Kuiken T, Herfst S, van Amerongen G, Yuksel S, Sprong L, Osterhaus AD. 2007. Immunization of macaques with formalin-inactivated human metapneumovirus induces hypersensitivity to hMPV infection. Vaccine 25: 8518-8528. http://dx.doi.org/10.1016/j.vaccine.2007.10.022.
240. Hamelin ME, Yim K, Kuhn KH, Cragin RP, Boukhvalova M, Blanco JC, Prince GA, Boivin G. 2005. Pathogenesis of human metapneumovirus lung infection in BALB/c mice and cotton rats. J Virol 79: 8894-8903. http://dx.doi.org/10.1128/JVI.79.14.8894-8903.2005.
241. Velayutham TS, Kolli D, Ivanciuc T, Garofalo RP, Casola A. 2013. Critical role of TLR4 in human metapneumovirus mediated innate immune responses and disease pathogenesis. PLoS One 8: e78849. http://dx.doi.org/10.1371/journal.pone.0078849.
242. Zhang Y, Niewiesk S, Li J. 2014. Small animal models for human metapneumovirus: cotton rat is more permissive than hamster and mouse. Pathogens 3: 633-655. http://dx.doi.org/10.3390/pathogens 3030633.
243. Goronzy JJ, Weyand CM. 2013. Understanding immunosenescence to improve responses to vaccines. Nat Immunol 14: 428-436. http://dx.doi.org/10.1038/ni.2588.
244. Shay T, Jojic V, Zuk O, Rothamel K, Puyraimond-Zemmour D, Feng T, Wakamatsu E, Benoist C, Koller D, Regev A, ImmGen Consortium. 2013. Conservation and divergence in the transcriptional programs of the human and mouse immune systems. Proc Natl Acad Sci U S A 110: 2946-2951. http://dx.doi.org/10.1073/pnas.1222738110.
245. Herd KA, Mahalingam S, Mackay IM, Nissen M, Sloots TP, Tindle RW. 2006. Cytotoxic T-lymphocyte epitope vaccination protects against human metapneumovirus infection and disease in mice. J Virol 80: 2034-2044. http://dx.doi.org/10.1128/JVI.80.4.2034-2044.2006.
246. + T cells. J Virol 89: 8713-8726. http://dx.doi.org/10.1128/JVI.00670-15.
247. Yamaguchi M, Kitagawa Y, Zhou M, Itoh M, Gotoh B. 2014. An anti-interferon activity shared by paramyxovirus C proteins: inhibition of Toll-like receptor 7/9-dependent alpha interferon induction. FEBS Lett 588: 28-34. http://dx.doi.org/10.1016/j.febslet.2013.11.015.
248. Henrickson KJ. 2003. Parainfluenza viruses. Clin Microbiol Rev 16: 242-264. http://dx.doi.org/10.1128/CMR.16.2.242-264.2003.
249. Ma X, Yang X, Nian X, Zhang Z, Dou Y, Zhang X, Luo X, Su J, Zhu Q, Cai X. 2015. Identification of amino-acid residues in the V protein of peste des petits ruminants essential for interference and suppression of STAT-mediated interferon signaling. Virology 483: 54-63. http://dx.doi.org/10.1016/j.virol.2015.03.039.
250. Rothlisberger A, Wiener D, Schweizer M, Peterhans E, Zurbriggen A, Plattet P. 2010. Two domains of the V protein of virulent canine distemper virus selectively inhibit STAT1 and STAT2 nuclear import. J Virol 84: 6328-6343. http://dx.doi.org/10.1128/JVI.01878-09.
251. Chinnakannan SK, Nanda SK, Baron MD. 2013. Morbillivirus V proteins exhibit multiple mechanisms to block type 1 and type 2 interferon signalling pathways. PLoS One 8: e57063. http://dx.doi.org/10.1371/journal.pone.0057063.
252. Childs K, Randall R, Goodbourn S. 2012. Paramyxovirus V proteins interact with the RNA helicase LGP2 to inhibit RIG-I-dependent interferon induction. J Virol 86: 3411-3421. http://dx.doi.org/10.1128/JVI.06405-11.
253. Andrejeva J, Childs KS, Young DF, Carlos TS, Stock N, Goodbourn S, Randall RE. 2004. The V proteins of paramyxoviruses bind the IFNinducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci U S A 101: 17264-17269. http://dx.doi.org /10.1073/pnas.0407639101.
254. Ramaswamy M, Shi L, Varga SM, Barik S, Behlke MA, Look DC. 2006. Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction. Virology 344: 328-339. http://dx.doi.org/10.1016/j.virol.2005.09.009.
255. Elliott J, Lynch OT, Suessmuth Y, Qian P, Boyd CR, Burrows JF, Buick R, Stevenson NJ, Touzelet O, Gadina M, Power UF, Johnston JA. 2007. Respiratory syncytial virus NS1 protein degrades STAT2 by using the elongin-cullin E3 ligase. J Virol 81: 3428-3436. http://dx.doi.org/10.1128/JVI.02303-06.
256. Malhotra R, Olsson H. 2015. Immunology, genetics and microbiota in the COPD pathophysiology: potential scope for patient stratification. Expert Rev Respir Med 9: 153-159. http://dx.doi.org/10.1586/17476348.2015.1000865.
257. von Messling V, Oezguen N, Zheng Q, Vongpunsawad S, Braun W, Cattaneo R. 2005. Nearby clusters of hemagglutinin residues sustain SLAM-dependent canine distemper virus entry in peripheral blood mononuclear cells. J Virol 79: 5857-5862. http://dx.doi.org/10.1128/JVI.79.9.5857-5862.2005.
258. Zipperle L, Langedijk JP, Orvell C, Vandevelde M, Zurbriggen A, Plattet P. 2010. Identification of key residues in virulent canine distemper virus hemagglutinin that control CD150/SLAM-binding activity. J Virol 84: 9618-9624. http://dx.doi.org/10.1128/JVI.01077-10.
259. Bonami F, Rudd PA, von Messling V. 2007. Disease duration determines canine distemper virus neurovirulence. J Virol 81: 12066-12070. http://dx.doi.org/10.1128/JVI.00818-07.
260. von Messling V, Svitek N, Cattaneo R. 2006. Receptor (SLAM [CD150]) recognition and the V protein sustain swift lymphocyte-based invasion of mucosal tissue and lymphatic organs by a morbillivirus. J Virol 80: 6084-6092. http://dx.doi.org/10.1128/JVI.00357-06.
261. Nakatsu Y, Takeda M, Ohno S, Shirogane Y, Iwasaki M, Yanagi Y. 2008. Measles virus circumvents the host interferon response by different actions of the C and V proteins. J Virol 82: 8296-8306. http://dx.doi.org /10.1128/JVI.00108-08.
262. Mayer V, Schulman JL, Kilbourne ED. 1973. Nonlinkage of neurovirulence exclusively to viral hemagglutinin or neuraminidase in genetic recombinants of A-NWS (HON1) influenza virus. J Virol 11: 272-278.
263. von Messling V, Milosevic D, Cattaneo R. 2004. Tropism illuminated:lymphocyte-based pathways blazed by lethal morbillivirus through the host immune system. Proc Natl Acad Sci U S A 101: 14216-14221. http://dx.doi.org/10.1073/pnas.0403597101.
264. Govindarajan D, Samal SK. 2004. Sequence analysis of the large polymerase (L) protein of the US strain of avian metapneumovirus indicates a close resemblance to that of the human metapneumovirus. Virus Res 105: 59-66. http://dx.doi.org/10.1016/j.virusres.2004.04.014.
265. Wen X, Krause JC, Leser GP, Cox RG, Lamb RA, Williams JV, Crowe JE, Jr, Jardetzky TS. 2012. Structure of the human metapneumovirus fusion protein with neutralizing antibody identifies a pneumovirus antigenic site. Nat Struct Mol Biol 19: 461-463. http://dx.doi.org/10.1038/nsmb.2250.
266. Leyrat C, Renner M, Harlos K, Grimes JM. 2013. Solution and crystallographic structures of the central region of the phosphoprotein from human metapneumovirus. PLoS One 8: e80371. http://dx.doi.org/10.1371/journal.pone.0080371.